Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

"What to consider when developing a clinical strategy for CE marking of a new medical device" by Nancy Boodhun, NAMSA

About Nancy: Nancy has over 17 years of experience of clinical research gained through in-house roles for medical device manufacturers. She currently holds the position of Clinical & Consulting Specialist at NAMSA, where she is able to transfer her knowledge to clients considering their clinical strategy and study execution for new product developments and post market requirements.

Please register via our Eventbrite link: